These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 8806513)
1. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells. Boppana SB; Britt WJ Virology; 1996 Aug; 222(1):293-6. PubMed ID: 8806513 [TBL] [Abstract][Full Text] [Related]
2. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs. Gyulai Z; Endresz V; Burian K; Pincus S; Toldy J; Cox WI; Meric C; Plotkin S; Gönczöl E; Berencsi K J Infect Dis; 2000 May; 181(5):1537-46. PubMed ID: 10823751 [TBL] [Abstract][Full Text] [Related]
3. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL. Wills MR; Carmichael AJ; Mynard K; Jin X; Weekes MP; Plachter B; Sissons JG J Virol; 1996 Nov; 70(11):7569-79. PubMed ID: 8892876 [TBL] [Abstract][Full Text] [Related]
4. Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus. Frankenberg N; Pepperl-Klindworth S; Meyer RG; Plachter B Virology; 2002 Apr; 295(2):208-16. PubMed ID: 12033779 [TBL] [Abstract][Full Text] [Related]
5. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells. Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452 [TBL] [Abstract][Full Text] [Related]
6. Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity. Borysiewicz LK; Morris S; Page JD; Sissons JG Eur J Immunol; 1983 Oct; 13(10):804-9. PubMed ID: 6196203 [TBL] [Abstract][Full Text] [Related]
8. Generation of cytotoxic T lymphocytes specific for human cytomegalovirus using dendritic cells in vitro. Cho HI; Han H; Kim CC; Kim TG J Immunother; 2001; 24(3):242-9. PubMed ID: 11394502 [TBL] [Abstract][Full Text] [Related]
9. Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H. Elkington R; Shoukry NH; Walker S; Crough T; Fazou C; Kaur A; Walker CM; Khanna R Eur J Immunol; 2004 Nov; 34(11):3216-26. PubMed ID: 15368271 [TBL] [Abstract][Full Text] [Related]
10. Human cytomegalovirus-specific cytotoxic T cells: their precursor frequency and stage specificity. Borysiewicz LK; Graham S; Hickling JK; Mason PD; Sissons JG Eur J Immunol; 1988 Feb; 18(2):269-75. PubMed ID: 2832181 [TBL] [Abstract][Full Text] [Related]
11. A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects. Berencsi K; Gyulai Z; Gönczöl E; Pincus S; Cox WI; Michelson S; Kari L; Meric C; Cadoz M; Zahradnik J; Starr S; Plotkin S J Infect Dis; 2001 Apr; 183(8):1171-9. PubMed ID: 11262198 [TBL] [Abstract][Full Text] [Related]
12. Detection of human cytomegalovirus-specific T lymphocytes in human blood: comparison of two methods. Schermann CM; Fischer G; Witt V; Kurz M; Potschger U; Fritsch G Cytotherapy; 2008; 10(8):834-41. PubMed ID: 19016371 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T cell immunity to human cytomegalovirus glycoprotein B. Hopkins JI; Fiander AN; Evans AS; Delchambre M; Gheysen D; Borysiewicz LK J Med Virol; 1996 Jun; 49(2):124-31. PubMed ID: 8991935 [TBL] [Abstract][Full Text] [Related]
14. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens. Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295 [TBL] [Abstract][Full Text] [Related]
15. Adoptive immunotherapy of HCMV infection. Kapp M; Tan SM; Einsele H; Grigoleit G Cytotherapy; 2007; 9(8):699-711. PubMed ID: 17917875 [TBL] [Abstract][Full Text] [Related]
16. Effect of serum and CTL on focal growth of human cytomegalovirus. Sinzger C; Mangin M; Weinstock C; Topp MS; Hebart H; Einsele H; Jahn G J Clin Virol; 2007 Feb; 38(2):112-9. PubMed ID: 17204454 [TBL] [Abstract][Full Text] [Related]
17. Characterization of antigen-specific repertoire diversity following in vitro restimulation by a recombinant adenovirus expressing human cytomegalovirus pp65. Hamel Y; Rohrlich P; Baron V; Bonhomme D; Rieux-Laucat F; Necker A; Lemonnier F; Ferradini L; Fischer A; Cavazzana-Calvo M Eur J Immunol; 2003 Mar; 33(3):760-8. PubMed ID: 12616496 [TBL] [Abstract][Full Text] [Related]
18. Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-gamma-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation. Hebart H; Daginik S; Stevanovic S; Grigoleit U; Dobler A; Baur M; Rauser G; Sinzger C; Jahn G; Loeffler J; Kanz L; Rammensee HG; Einsele H Blood; 2002 May; 99(10):3830-7. PubMed ID: 11986243 [TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses. Borysiewicz LK; Hickling JK; Graham S; Sinclair J; Cranage MP; Smith GL; Sissons JG J Exp Med; 1988 Sep; 168(3):919-31. PubMed ID: 2844952 [TBL] [Abstract][Full Text] [Related]
20. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection. Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]